返回
Vemurafenib (PLX4032, RG7204)

Vemurafenib (PLX4032, RG7204)

Solutions:Cell Biology,Life Science

Origin:USA


Product descriptionVemurafenib (PLX4032, RG7204) is a new type of effective B-RafV600E inhibitor, in which the IC50 was 31 nM in the no cell test.
TargetSRMS [1]
(Cell-free assay)
ACK1 [1]
(Cell-free assay)
B-Raf (V600E) [1]
(Cell-free assay)
C-Raf [1]
(Cell-free assay)
MAP4K5 (KHS1)[1]
(Cell-free assay)

View More

IC5018 nM19 nM31 nM48 nM51 nM
In vitro studyPLX4032 inhibited B-RAFV600E, C-RAF, and wild-type B-RAF, IC50 were 31 nM, 48 nM, and 100 nM, respectively. PLX4032 also inhibited some non -RAF kinases, including ACK1, KHS1, and SRMS, IC50 18 nM to 51 nM. The effect of PLX4032 on melanoma cell lines, the inhibitory effect depends on the B-RAF mutation status, because PLX4032 inhibit B-RAFV600 containing mutant cells, including V600E, V600D, V600K, and V600R, but the wild type or other mutations have no effect. When PLX4032 acted on MALME-3M, Colo829, Colo38, A375, SK-MEL28, and A2058 cells, IC50 was 20 nM to 1 M. 0.1 M to 30 M PLX4032 also inhibited the phosphorylation of MEK1/2 and ERK1/2. PLX4032 is highly effective in the treatment of melanoma because PLX4032 effectively inhibits B-RAFV600E. PLX4032 acts on colon cancer cells and inhibits the rapid response of B-RAF to V600E leading to EGFR activation, which can be used to compensate for PLX4032 inhibition of cell proliferation.
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
A375Growth Inhibition Assay100 μM96 hDMSOIC50=47 nM18458053
AROGrowth Inhibition Assay100 μM96 hDMSOIC50=205 nM18458053
NPAGrowth Inhibition Assay100 μM96 hDMSOIC50=26 nM18458053

... Click to View More Cell Line Experimental Data

In vivo studyPLX4032 was treated with 6 mg/kg-20 mg/kg dose in the transplanted tumor model of B-RAFV600E- mutant mice to inhibit tumor growth.  PLX4032 dose 12.5 mg/kg-100 mg/kg in mice carrying LOX, Colo829, and A375, inhibit tumor growth and prolong the life span of mice.
FeaturesPLX4032 is a novel and effective inhibitor of B-RAFV600E tumor protein.


Copyright © 2018 LIFESIS All Rights Reserved.

苏ICP备09044010号

Copyright © 2018 拜诺生物 All Rights Reserved.

苏ICP备09044010号